Company news

GlycoNex, Inc. news in 2026

GlycoNex, Inc.'s news releases, calls and decks from 2026, newest first.

GlycoNex Doses First Patient in Phase I Trial of GNX1021, Advancing Its Glycan-Directed ADC into Clinical Development

August 2, 2026

GlycoNex Receives PMDA Approval in Japan to Initiate First-in-Human Phase 1 Trial of GNX1021 in Gastrointestinal Cancers

April 14, 2026

GlycoNex Inc. and Nippon Kayaku Co., Ltd. Enter Collaboration to Advance Next-Generation ADC Candidate GNX201-ADC

March 23, 2026

Decks in 2026

Investor Presentation (September 2026)
Investor deck · 23 slides · Sep 17, 2026